Actinium-225 Urine Analysis with Oxidative Sample Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for measuring actinium-225 in urine samples are inefficient due to the presence of high organic matter, which affects alpha resolution and requires lengthy filtration times, and do not effectively remove matrix and radiological interferences.
Innovation Solution
A method involving TiO)3(PO4)2 co-precipitation followed by KBrO3 treatment to break down organic matter, combined with DGA resin purification, to prepare and purify urine samples for accurate alpha spectrometry measurement.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional filtration methods are used to remove organic matter from urine samples, then the sample can be prepared for measurement, but the filtration time becomes excessively long and alpha resolution is degraded
Solution Approach 1:
The patent changes the chemical parameters of the urine sample by adjusting pH to specific ranges (pH 2-4) and adding chemical reagents that modify the solubility and precipitation characteristics of organic matter and actinium. This allows rapid separation without prolonged filtration, maintaining alpha resolution while reducing time loss.
Solution Approach 2:
The patent employs strong oxidants to rapidly decompose organic matter in the urine sample. This oxidation process breaks down complex organic molecules into simpler, filterable forms or volatile products, enabling quick removal of organics without lengthy filtration procedures and preserving measurement precision.
2Measurement precision
If conventional purification methods are used to remove matrix and radiological interferences, then accurate measurement of actinium-225 can be achieved, but the process complexity and time required increase
Solution Approach 1:
The patent segments the purification process into distinct functional steps: (1) precipitation of actinium using specific reagents, (2) selective dissolution of precipitate, (3) filtration of interferences, and (4) final purification. This segmentation allows each step to target specific interferences systematically, achieving high detection accuracy while managing process complexity through structured approach.
Solution Approach 2:
The patent introduces intermediary substances (chemical reagents and carriers) that facilitate the removal of matrix and radiological interferences. These intermediaries act as mediators that selectively bind to or precipitate with interfering substances, allowing their removal without directly affecting actinium-225, thus simplifying the overall purification process while maintaining detection accuracy.
3Measurement precision
If the urine sample is processed to remove organic matter, then accurate measurement is enabled, but chemical recovery is reduced due to losses during processing
Solution Approach 1:
The patent incorporates feedback mechanisms through spiking samples with known amounts of actinium-225 before processing. By measuring the recovery of the spiked amount through the entire processing sequence, the method allows for calculation and application of recovery correction factors. This feedback loop enables accurate measurement while accounting for and compensating for chemical losses during processing steps.
Solution Approach 2:
The patent optimizes processing parameters (pH, temperature, reagent concentrations, contact times) to minimize chemical losses. By carefully controlling these parameters, the method maintains high chemical recovery while still achieving effective removal of organic matter, thus preserving both measurement accuracy and substance recovery.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves rapid and effective removal of organic matter and interferences, allowing for high chemical recovery and low minimal detectable activity, suitable for monitoring internal dose contamination.
Implementation Method 1
The method involves TiO3(PO4)2 co-precipitation followed by KBrO3 treatment
Implementation Method 2
KBrO3 treatment to break down organic matter
Implementation Method 3
DGA resin purification
Implementation Method 4
alpha spectrometry measurement
Data Source
AI summary
Methods of determining actinium-225 in a human urine sample can be used to establish the effective dose received by persons working with or otherwise exposed to this isotope. The human urine sample can be prepared to produce a pre-concentrated sample, which can include co-precipitating Ac and separating a first precipitate. At least some organic matter can be broken down in the pre-concentrated sample to produce a decomposed sample, which can include adding an oxidative agent to the pre-concentrated sample. The decomposed sample can be purified to produce a measurement sample, which can include passing the decomposed sample through a purification media and eluting actinium from the purification media.